Sign in
Not yet recruitingNo phase

Deep TMS for PTSD With Suicidal Ideation

Key facts

Who runs it
D.R. Rut Zaks OHAYON
Where
Israel1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
72 people, planned
Started
Oct 2026
Expected to end
Oct 2029
Type of study
Interventional
Treatments tested
  • Deep Transcranial Magnetic Stimulation (DTMS)
Record updated
19 October 2026

Who can take part

Age
22 years to 68 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • Adults 22-68 years old
  • Male or female
  • Diagnosis of PTSD according to DSM-5 criteria
  • Active suicidal ideation at screening, confirmed by the Beck Scale for Suicide Ideation (SSI)
  • Able to provide informed consent
  • Stable psychiatric medication regimen for at least 4 weeks prior to enrollment (if applicable)
  • Able to comply with study procedures and attend scheduled sessions

Who cannot take part

  • Prior non-response to adequate TMS treatment
  • Current psychotic disorder, bipolar disorder, or severe personality disorder
  • Substance use disorder within the past 3 months (excluding nicotine or caffeine)
  • Significant neurological disorder or history of seizures
  • Contraindications to TMS (e.g., metallic implants in the head, implanted medical devices, history of epilepsy)
  • Current use of medications that significantly lower seizure threshold
  • Acute medical illness or unstable medical condition
  • Cognitive impairment that would interfere with participation (based on MoCA)
  • Pregnancy or breastfeeding
  • Imminent risk requiring a higher level of care (e.g., hospitalization)
  • Participation in another interventional study within the past 30 days

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Post traumatic stress disorder PTSD or suicidal ideation

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate whether deep transcranial magnetic stimulation (DTMS) using the H1-coil can safely and effectively reduce suicidal ideation in adults diagnosed with post-traumatic stress disorder (PTSD). The main questions it aims to answer are: (1) Does DTMS reduce suicidal ideation in adults with PTSD? (2) Does DTMS improve PTSD symptoms?. DTMS is administered together with a brief exposure procedure intended to activate trauma-related neural circuits before stimulation.

The group in the trial

  • DTMS with ExposureTreatment being tested

    High-frequency Deep TMS using the H1-coil, with each session preceded by a brief script-driven exposure procedure.

    Treatment: Deep Transcranial Magnetic Stimulation (DTMS)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective Study to Evaluate the Safety and Efficacy of Deep Transcranial Magnetic Stimulation (DTMS) for the Treatment of PTSD-Associated Suicidal Ideation (PTSD-SI)
Criteria questions
Built from NCT07880340, who can take part
Record updated
19 October 2026